Zobrazeno 1 - 7
of 7
pro vyhledávání: '"W. N. Katkov"'
Autor:
W. N. Katkov
Publikováno v:
Archives of Internal Medicine. 151:1548-1552
Autor:
D. W. Yandell, Cosimi Ab, Sanjay Saini, W. N. Katkov, John A. Powelson, Judith A. Ferry, Chuan Li, Ira J. Spiro
Publikováno v:
New England Journal of Medicine. 329:27-29
Non-Hodgkin's lymphoma after organ transplantation is a recognized complication of immunosuppressive therapy. A number of cases of post-transplantation lymphoma arising in allografted tissue have been described1. In addition, leukemia and lymphoma ar
Autor:
K L, Lindsay, G L, Davis, E R, Schiff, H C, Bodenheimer, L A, Balart, J L, Dienstag, R P, Perrillo, C H, Tamburro, J S, Goff, G T, Everson, M, Silva, W N, Katkov, Z, Goodman, J Y, Lau, G, Maertens, J, Gogate, B, Sanghvi, J, Albrecht
Publikováno v:
Hepatology (Baltimore, Md.). 24(5)
To evaluate response rates to 3, 5, or 10 million units (MU) of interferon alfa-2b, given thrice weekly, and to determine whether higher doses of interferon increase the likelihood or durability of the response, a multicenter, randomized trial was pe
Autor:
W N, Katkov, J L, Dienstag
Publikováno v:
Gastroenterology clinics of North America. 24(1)
The 1980s represented a decade of breakthroughs for the development of hepatitis vaccines. Plasma-derived and then recombinant hepatitis B vaccines were developed and introduced, killed hepatitis A vaccine was developed, and the virologic tools were
Publikováno v:
The New England journal of medicine. 329(1)
Publikováno v:
Archives of internal medicine. 151(8)
To assess the contribution of the recently identified hepatitis C virus to chronic liver diseases of unknown cause and chronic hepatitis attributed by exclusion to non-A, non-B hepatitis, we tested for antibody to hepatitis C in hepatitis B surface a
Publikováno v:
Archives of pathologylaboratory medicine. 113(11)
Vaccination against hepatitis B is readily available and provides safe and effective immunization for individuals at increased risk for this disease. However, since the available vaccines employ a protein consisting of hepatitis B surface antigen, th